These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 24618835

  • 21. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
    Bowers LW, Cavazos DA, Maximo IX, Brenner AJ, Hursting SD, deGraffenried LA.
    Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
    [Abstract] [Full Text] [Related]

  • 22. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
    Elumalai P, Arunkumar R, Benson CS, Sharmila G, Arunakaran J.
    Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
    [Abstract] [Full Text] [Related]

  • 23. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A.
    Oncotarget; 2016 Feb 16; 7(7):7683-700. PubMed ID: 26655502
    [Abstract] [Full Text] [Related]

  • 24. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J, Zeng J, Xin M, Huang W, Chen X.
    Horm Metab Res; 2011 Sep 16; 43(10):681-6. PubMed ID: 21932171
    [Abstract] [Full Text] [Related]

  • 25. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK, Sanders BG, Kline K.
    Breast Cancer Res Treat; 2010 Nov 16; 124(2):361-75. PubMed ID: 20157774
    [Abstract] [Full Text] [Related]

  • 26. Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/Akt signaling pathway.
    Fang Y, Xue Z, Zhao L, Yang X, Yang Y, Zhou X, Feng S, Chen K.
    Cell Biol Int; 2019 Mar 16; 43(3):323-332. PubMed ID: 30632644
    [Abstract] [Full Text] [Related]

  • 27. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
    Gaben AM, Sabbah M, Redeuilh G, Bedin M, Mester J.
    BMC Cancer; 2012 Jul 16; 12():291. PubMed ID: 22799881
    [Abstract] [Full Text] [Related]

  • 28. Role of androgen receptor on cyclic mechanical stretch-regulated proliferation of C2C12 myoblasts and its upstream signals: IGF-1-mediated PI3K/Akt and MAPKs pathways.
    Ma Y, Fu S, Lu L, Wang X.
    Mol Cell Endocrinol; 2017 Jul 15; 450():83-93. PubMed ID: 28454723
    [Abstract] [Full Text] [Related]

  • 29. IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer.
    Kruger DT, Alexi X, Opdam M, Schuurman K, Voorwerk L, Sanders J, van der Noort V, Boven E, Zwart W, Linn SC.
    Int J Cancer; 2020 Apr 15; 146(8):2348-2359. PubMed ID: 31490549
    [Abstract] [Full Text] [Related]

  • 30. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
    Luey BC, May FE.
    Mol Cancer; 2016 Jan 22; 15():8. PubMed ID: 26801096
    [Abstract] [Full Text] [Related]

  • 31. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.
    Davison Z, de Blacquière GE, Westley BR, May FE.
    Neoplasia; 2011 Jun 22; 13(6):504-15. PubMed ID: 21677874
    [Abstract] [Full Text] [Related]

  • 32. Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
    Wang C, Xu CX, Bu Y, Bottum KM, Tischkau SA.
    Carcinogenesis; 2014 Mar 22; 35(3):703-13. PubMed ID: 24163404
    [Abstract] [Full Text] [Related]

  • 33. Signaling pathways activated by PACAP in MCF-7 breast cancer cells.
    Zibara K, Zeidan A, Mallah K, Kassem N, Awad A, Mazurier F, Badran B, El-Zein N.
    Cell Signal; 2018 Oct 22; 50():37-47. PubMed ID: 29935235
    [Abstract] [Full Text] [Related]

  • 34. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
    Tian J, Duan YX, Bei CY, Chen J.
    Horm Metab Res; 2013 Aug 22; 45(8):593-8. PubMed ID: 23609007
    [Abstract] [Full Text] [Related]

  • 35. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
    Zhang H, Zheng XD, Zeng XH, Li L, Zhou Q.
    Yakugaku Zasshi; 2021 Mar 01; 141(3):415-426. PubMed ID: 33116033
    [Abstract] [Full Text] [Related]

  • 36. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
    Lam L, Hu X, Aktary Z, Andrews DW, Pasdar M.
    Breast Cancer Res Treat; 2009 Dec 01; 118(3):605-21. PubMed ID: 19002577
    [Abstract] [Full Text] [Related]

  • 37. Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.
    Mendoza RA, Enriquez MI, Mejia SM, Moody EE, Thordarson G.
    J Endocrinol; 2011 Jan 01; 208(1):1-9. PubMed ID: 20974640
    [Abstract] [Full Text] [Related]

  • 38. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells.
    Chen J, Zhao X, Li X, Wu Y.
    Food Funct; 2015 Sep 01; 6(9):3091-7. PubMed ID: 26215320
    [Abstract] [Full Text] [Related]

  • 39. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
    Dhar K, Banerjee S, Dhar G, Sengupta K, Banerjee SK.
    Cancer Res; 2007 Feb 15; 67(4):1520-6. PubMed ID: 17308090
    [Abstract] [Full Text] [Related]

  • 40. p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.
    Meng F, Zhang H, Liu G, Kreike B, Chen W, Sethi S, Miller FR, Wu G.
    Neoplasia; 2011 May 15; 13(5):472-82. PubMed ID: 21532888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.